Is CapsoVision, Inc. (CV) Overvalued?
We dive into why CapsoVision, Inc. (CV) could be considered overvalued on 2026-08-17, based on AAII’s Value Score and Grade.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Commentary & Analysis
Why CapsoVision, Inc.’s (CV) Stock Is Down 7.47%
As of Friday, August 14, CapsoVision, Inc.’s CV share price has dipped by 7.47%, which has investors questioning if this is right time to buy.Jenna Brashear
Why CapsoVision, Inc.’s (CV) Stock Is Down 5.33%
As of Wednesday, August 05, CapsoVision, Inc.’s CV share price has dipped by 5.33%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why CapsoVision, Inc.’s (CV) Stock Is Up 6.23%
As of Monday, August 03, CapsoVision, Inc.’s CV share price has surged by 6.23%, which has investors questioning if this is right time to sell.Jenna Brashear
Why CapsoVision, Inc.’s (CV) Stock Is Down 5.07%
As of Thursday, July 23, CapsoVision, Inc.’s CV share price has dipped by 5.07%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | CV | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $295.3 | $407.7 | 31% |
|
| Shares Out (Mil) | 49.9 | 41.3 | 47% |
|
| Institutional Ownership | 25.4% | 81.4% | 12% |
|
| Float (Mil) | 31.5 | 34.9 | 37% |
|
| Beta | na | 0.88 | na |
|
| Avg Daily Volume (000s) | 102 | 412 | 35% |
|
| Price Change (52-week) |
51.7% | 64.8% | 80% |
|
| Growth | CV | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (6.0%) | na |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | CV | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $14 | $119 | 11% |
|
| Net Income (TTM) (Mil) | ($30) | ($9) | 21% |
|
| EPS (TTM) | ($0.624) | ($0.400) | 25% |
|
| Operating Cash Flow (TTM) (Mil) | ($28) | ($3) | 13% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $1 | 55% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $21 | 12% |
|
| Enterprise Value (Q1) (Mil) | $315 | $427 | 30% |
|
| Valuation | CV | Industry Median |
Percentile (All Stocks) |
|
| P/B | 22.69 | 3.06 | 96% |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | CV | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 50.9% | 58.9% | 63% |
|
| Net Margin | (214.7%) | (6.9%) | 4% |
|
| ROA | (212.2%) | (12.7%) | 2% |
|
| ROE | 47.4% | (13.1%) | 92% |
|
| Liabilities to Assets | 29.1% | 46.0% | 21% |
|
| F-Score | 2 | 4 | 7% |
|
CapsoVision, Inc. did not pass any screens on 8/20/2026.
